SUBSCRIBE
SUBSCRIBE

Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS
Insights
From MSCs to iPSCs: building the cell therapy future
In this episode of Denatured, you’ll be hearing from Miguel Forte, president of the International Society for Cell and Gene Therapy (ISCT), and Jon Ellis, co-founder & CEO of Trenchant Bios, speaking live from the ISCT annual meeting. We dive into mesenchymal stem cells and induced pluripotent stem cells, exploring the science behind them, the manufacturing challenges, and the potential for scalable, engineered next-generation therapies.
May 14, 2026
 · 
1 min read
 · 
Jennifer C. Smith-Parker
Hiring collage showing HR checking applicant information
Job Trends
Hiring outlook: job opportunities on BioSpace rise YOY, but layoffs affect thousands
While average job postings live on BioSpace have increased year over year for nearly every month of 2026, the number of employees affected by made or planned layoffs by the end of that same period nearly matched what was seen in 2025.
May 14, 2026
 · 
3 min read
 · 
Angela Gabriel
USA, Scenic San Diego downtown financial district city skyline and skyscrapers.
Job Trends
17 companies hiring in California
Looking for a biopharma job in California? Check out the BioSpace list of 17 companies hiring life sciences professionals like you.
May 14, 2026
 · 
3 min read
 · 
Angela Gabriel
Smart industry and digital manufacturing concept with glowing polygonal factory connected to circuit board on dark blue background. Futuristic low poly style, abstract vector illustration.
Manufacturing
Bora inks $122.5M takeover of MacroGenics facility to further US expansion
MacroGenics is selling the manufacturing plant to Bora, a Taiwan-based CDMO, to raise cash to support the progress of its drug development pipeline.
May 13, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Aerial view from window plane of San Cristobal at Galapagos island, Ecuador
Earnings
Goodbye Galapagos: chameleon company exits the island, rebrands as Lakefront
After a 12-month period that saw the Belgian biotech consider a spinout, swap out CEOs, and enter a three-way acquisition agreement involving Ouro Medicines, Galapagos now has a new moniker.
May 13, 2026
 · 
2 min read
 · 
Heather McKenzie
Businessman pulling rope trying to lift up falling graph.
Complete response letters
UniQure, Replimune shares rise as FDA’s Makary exits, but path forward unchanged
After devastating regulatory setbacks last year, shares of uniQure and Replimune rose on the news that FDA Commissioner Marty Makary is leaving. But analysts don’t expect much relief, no matter who helms the agency.
May 13, 2026
 · 
3 min read
 · 
Annalee Armstrong
FDA
Makary’s out at FDA, Sanofi’s priority voucher issues, top exec pay
It’s official: FDA Commissioner Marty Makary is out at the FDA after reports of his ouster emerged late last week; Sanofi is reportedly having challenges with one of the FDA’s new signature programs; and biopharma CEOs’ multimillion-dollar salaries ticked up again this year. Who made the most in 2025?
May 13, 2026
 · 
1 min read
 · 
Heather McKenzie
leader crossed forbidden line, leadership vector concept, finish line and winner
Obesity
Lilly maintains weight loss leadership as Foundayo, Zepbound keep pounds off after switching
Despite seeing some regain, patients in two trials maintained most of their weight loss after switching to either Foundayo or lower-dose Zepbound from other injectable incretin therapies.
May 13, 2026
 · 
2 min read
 · 
Tristan Manalac
Large hand making pressure over group of small, silhouetted figures. Oppressions, manipulation. Contemporary art collage. Photocopy effect. Concept of world crisis, business, economy, control
FDA
After ‘most damaging period in FDA history,’ Makary will be hard to replace
With Commissioner Marty Makary’s exit, the FDA will enter a period of “unprecedented” and “prolonged” leadership vacuum, analysts at Capital Alpha predicted, noting that the government will have trouble finding someone who will want to take the FDA’s reins.
May 13, 2026
 · 
3 min read
 · 
Tristan Manalac
Load More
Visit website
Email Us
IN THE PRESS
Press Releases
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
June 2, 2025
 · 
4 min read
BioMidwest
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 8, 2022
 · 
4 min read
Business
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 2, 2020
 · 
4 min read
JOBS